<DOC>
	<DOCNO>NCT00762541</DOCNO>
	<brief_summary>The purpose study determine whether MEL 80 Excimer Laser effective treatment moderate high myopia ( nearsightedness ) , use part Laser In Situ Keratomileusis ( LASIK ) procedure .</brief_summary>
	<brief_title>Study MEL 80 Excimer Laser Using LASIK Treatment Moderate High Myopia</brief_title>
	<detailed_description>LASIK become one common refractive eye procedure perform country . Currently MEL 80 Excimer Laser System approve elimination myopia less equal -7.0 D without refractive astigmatism less equal -3.0 D , maximum MRSE -7.00 D. The goal study assess safety effectiveness information treatment moderate high magnitude myopia .</detailed_description>
	<mesh_term>Myopia</mesh_term>
	<criteria>Myopia &gt; 7.00 D 12.00 D , astigmatism le equal 6.00 D spectacle plane , maximum MRSE â‰¤12.00 D. Stable refraction least last twelve month , demonstrate change le 1.00 D spherical equivalent twelve month prior baseline examination eye treat , document previous clinical record . Discontinue use contact lenses least 2 week hard contact 3 day soft lens prior preoperative examination . Hard contact lens wearer must two central keratometry reading two manifest refraction take least one week apart differ 0.50 D. Visual acuity correctable least 20/40 eye . UCVA 20/40 bad operative eye . At least 18 year age . Operative eye must target emmetropia . Have normal corneal topography . Willing able return schedule follow examination twelve month surgery . Sign give copy write Informed Consent form . History anterior segment pathology , include cataract ( operative eye ) . Clinically significant dry eye syndrome unresolved treatment . Residual , recurrent , active ocular uncontrolled eyelid disease , corneal scar within ablation zone corneal abnormality recurrent corneal erosion severe basement membrane disease . Ophthalmoscopic sign progressive unstable myopia keratoconus ( keratoconus suspect ) . An ablation deeper 250 micron corneal endothelium . Irregular unstable ( distorted/not clear ) corneal mire central keratometry reading . Blind fellow eye . Undergone previous intraocular corneal surgery kind operative eye ( ) , include type surgery either refractive therapeutic purpose . History ocular Herpes zoster Herpes simplex keratitis . History steroidresponsive rise intraocular pressure , glaucoma , preoperative IOP &gt; 21 mm Hg . Must diabetes , diagnose autoimmune disease , connective tissue disease , clinically significant atopic syndrome . Must immunocompromised use chronic systemic corticosteroid immunosuppressive therapy . Patients must pregnant , lactate , childbearing potential practicing medically approve method birth control . Patients must know sensitivity plan study medication . Patients must participate ophthalmic drug device clinical trial time clinical investigation . For Fellow ( Second ) Eyes Simultaneous Bilateral Treatment Procedures 1 . Flap complication first eye 's surgery free cap , partial flap , thin flap , irregular flap . 2 . Epithelial defect exceed 2 mm x 2 mm dimension , clinically significant debris interface flap underlie stroma first eye . 3 . Severe blepharospasm first eye may prevent impeded completion keratectomy and/or laser ablation procedure . 4 . Poor subject cooperation instruction first eye 's surgery and/or poor subject fixation laser fixation target . 5 . Aborted LASIK procedure first eye PRK perform first eye LASIK possible .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Myopia</keyword>
	<keyword>Laser In Situ Keratomileusis</keyword>
	<keyword>Laser Therapy</keyword>
	<keyword>Laser Corneal Surgery</keyword>
	<keyword>Refractive Surgical Procedures</keyword>
	<keyword>Ophthalmologic Surgical Procedure</keyword>
	<keyword>Operative Surgical Procedures</keyword>
	<keyword>Therapeutics</keyword>
</DOC>